glutamine has been researched along with glucagon-like peptide 1 in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Gregor, M; Hartmann, F; Plauth, M; Raible, A | 1 |
| Blazquez, E; Calvo, JC; Gisolfi, CV; Mora, F | 1 |
| Goto, N; Kameyama, T; Oka, JI | 1 |
| Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP | 1 |
| da Silva Xavier, G; Gribble, FM; Reimann, F; Rutter, GA; Williams, L | 1 |
| Blackwood, A; Farooqi, IS; Greenfield, JR; Gribble, FM; Habib, AM; Henning, E; Holst, JJ; Keogh, JM; Reimann, F | 1 |
| Awad, S; Blackshaw, PE; Lobo, DN; Macdonald, IA; Perkins, AC; Wright, JW | 1 |
| Gribble, FM; Habib, AM; Parker, HE; Reimann, F; Tolhurst, G; Zheng, Y | 1 |
| Chisholm, DJ; Douglas, A; Greenfield, JR; Gribble, FM; Holst, JJ; Piyaratna, N; Samocha-Bonet, D; Synnott, EL; Wong, O | 1 |
| Hosseini, S; Larijani, B; Mansour, A; Mohajeri-Tehrani, MR; Pajouhi, M | 1 |
| Badole, SL; Bagul, PP; Coutinho, EC; Ghule, AE; Jangam, GB; Joshi, AC; Khedkar, VM; Khose, RD; Mahamuni, SP; Raut, CG | 1 |
| Chang, J; Greenfield, JR; Horowitz, M; Rayner, CK; Samocha-Bonet, D; Wu, T | 1 |
| Cox, HM; Joshi, S; Tough, IR | 1 |
| Badole, SL; Bagul, PP; Chaudhari, SM; Joshi, AC; Khose, RD; Mahamuni, SP; Raut, CG; Zanwar, AA | 1 |
| Crema, E; da Silva, AA; da Silva, LM; Takeuti, TD; Terra, GA; Terra, JA | 1 |
| Chisholm, DJ; Greenfield, JR; Holst, JJ; Samocha-Bonet, D | 1 |
| Gribble, F; Lewis, HB; Meek, CL; Park, A; Reimann, F; Vergese, B | 1 |
| Darmaun, D; Hossain, J; Mauras, N; Torres-Santiago, L; Weltman, AL | 1 |
| Al-Majdoub, M; Andersson, LE; Arroyo, CB; Aste Carrara, J; Fex, M; Mulder, H; Shcherbina, L; Spégel, P; Vishnu, N; Wierup, N; Wollheim, CB | 1 |
| El-Sayed, NM; Medras, ZJH; Moustafa, YM; Sami, MM; Toraih, EA; Zaitone, SA | 1 |
| Darmaun, D; Mauras, N; Torres-Santiago, L | 1 |
| Gütschow, M; Harada, K; Kamiya, T; Kato, T; Kitaguchi, T; Küppers, J; Nakajima, K; Nakamura, T; Ohta, K; Takizawa, M; Tsuboi, T | 1 |
3 review(s) available for glutamine and glucagon-like peptide 1
| Article | Year |
|---|---|
Inter-organ communication between intestine and liver in vivo and in vitro.
Topics: Animals; Cell Communication; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glutamine; Humans; Intestines; Liver; Peptide Fragments; Perfusion; Protein Precursors | 1993 |
Nutrients related to GLP1 secretory responses.
Topics: Animals; Cell Proliferation; Diabetes Mellitus, Type 2; Dietary Fats; Dietary Fiber; Dietary Proteins; Gastric Emptying; Glucagon-Like Peptide 1; Glutamine; Humans; Insulin; Insulin Resistance; Non-Nutritive Sweeteners; Postprandial Period | 2013 |
Glutamine and type 1 diabetes mellitus: is there a role in glycemic control?
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Glucagon-Like Peptide 1; Gluconeogenesis; Glutamine; Glutathione; Homeostasis; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Secretion; Randomized Controlled Trials as Topic | 2019 |
7 trial(s) available for glutamine and glucagon-like peptide 1
| Article | Year |
|---|---|
Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glutamine; Humans; Insulin; Insulin Secretion; Male; Obesity; Thinness | 2009 |
A randomized crossover study of the effects of glutamine and lipid on the gastric emptying time of a preoperative carbohydrate drink.
Topics: Adolescent; Adult; Beverages; Blood Glucose; Carbohydrate Metabolism; Carbohydrates; Cross-Over Studies; Dietary Supplements; Eating; Ethnicity; Gastric Emptying; Glucagon-Like Peptide 1; Glutamine; Humans; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Preoperative Care; Single-Blind Method; Technetium Tc 99m Pentetate; White People; Young Adult | 2011 |
Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glutamine; Humans; Hyperglycemia; Insulin; Insulin Secretion; Male; Middle Aged; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Duodenum; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glutamine; Healthy Volunteers; Humans; Incretins; Insulin; Insulin Secretion; Male | 2013 |
L-glutamine and whole protein restore first-phase insulin response and increase glucagon-like peptide-1 in type 2 diabetes patients.
Topics: Adult; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Female; Glucagon-Like Peptide 1; Glutamine; Humans; Insulin; Male; Middle Aged | 2015 |
The effect of encapsulated glutamine on gut peptide secretion in human volunteers.
Topics: Adult; Aged; Appetite; Appetite Depressants; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glutamine; Humans; Insulin; Male; Middle Aged; Young Adult | 2016 |
Does oral glutamine improve insulin sensitivity in adolescents with type 1 diabetes?
Topics: Adolescent; Blood Glucose; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 1; Dietary Supplements; Double-Blind Method; Exercise; Fatty Acids, Nonesterified; Female; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glutamine; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male | 2017 |
12 other study(ies) available for glutamine and glucagon-like peptide 1
| Article | Year |
|---|---|
Glucagon-like peptide-1(7-36)amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat.
Topics: Animals; Aspartic Acid; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glutamine; Hypothalamus, Middle; Male; Microdialysis; Neurotransmitter Agents; Peptide Fragments; Rats; Rats, Wistar | 1995 |
Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus.
Topics: Animals; Aspartic Acid; Cerebral Cortex; Electroencephalography; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glutamic Acid; Glutamine; Hippocampus; Injections, Intraventricular; Male; Neurons; Peptide Fragments; Peptides; Protein Precursors; Rats; Rats, Wistar; Receptors, Glucagon; Stimulation, Chemical; Ventromedial Hypothalamic Nucleus | 1999 |
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Topics: Adenosine Deaminase; Amino Acid Substitution; Animals; Binding, Competitive; Blood Glucose; Cell Line, Tumor; Cricetinae; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fibroblasts; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutamine; Glycoproteins; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Peptide Fragments; Phenylalanine; Proline; Protein Precursors; Rats; Receptors, Glucagon; Spectrometry, Mass, Electrospray Ionization; Transformation, Genetic; Tyrosine | 2003 |
Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells.
Topics: Adenosine Triphosphate; Animals; Base Sequence; Calcium; Cell Line; DNA Primers; Electrophysiology; Glucagon; Glucagon-Like Peptide 1; Glutamine; Kinetics; Mice; Peptide Fragments; Peptide YY; Protein Precursors; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP.
Topics: Animals; Calcium; Cells, Cultured; Cyclic AMP; Flow Cytometry; Fluorescence Resonance Energy Transfer; Glucagon-Like Peptide 1; Glutamine; Mice; Oligonucleotide Array Sequence Analysis; Signal Transduction | 2011 |
Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Colon; Diabetes Mellitus, Experimental; Drinking; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Glutamine; Glycated Hemoglobin; Insulin; Lipid Metabolism; Male; Molecular Docking Simulation; Niacinamide; Oxidative Stress; Pancreas; Peptide Fragments; Protein Conformation; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles | 2013 |
Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.
Topics: Animals; Colon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutamine; Hormone Antagonists; Intestinal Mucosa; Jejunum; Male; Membrane Potentials; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Paracrine Communication; Peptide YY; Receptors, Calcium-Sensing; Receptors, G-Protein-Coupled; Receptors, Glucagon; Receptors, Neuropeptide Y | 2013 |
Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats.
Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Colon; Diabetes Mellitus, Experimental; Drinking Behavior; Feeding Behavior; Glucagon-Like Peptide 1; Glutamine; Glycated Hemoglobin; Insulin; Lipid Metabolism; Male; Niacinamide; Oxidative Stress; Pancreas; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Staining and Labeling; Streptozocin; Triazoles; Triterpenes | 2013 |
Effect of the ingestion of the palm oil and glutamine in serum levels of GLP-1, PYY and glycemia in diabetes mellitus type 2 patients submitted to metabolic surgery.
Topics: Adult; Bariatric Surgery; Blood Glucose; Diabetes Mellitus, Type 2; Eating; Female; Glucagon-Like Peptide 1; Glutamine; Humans; Male; Middle Aged; Palm Oil; Peptide YY; Plant Oils; Young Adult | 2014 |
Glutamine-Elicited Secretion of Glucagon-Like Peptide 1 Is Governed by an Activated Glutamate Dehydrogenase.
Topics: Administration, Rectal; Animals; Catechin; Cell Line; Enteroendocrine Cells; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Glucagon-Like Peptide 1; Glucose; Glutamate Dehydrogenase; Glutamates; Glutamine; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice, Inbred C57BL; Mitochondria; Models, Biological; Peptide Fragments; Rats; Single-Cell Analysis | 2018 |
Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats.
Topics: Amino Acid Transport System A; Amino Acid Transport Systems; Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glutamine; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Liraglutide; Male; Pancreas; Rats; Streptozocin; Up-Regulation | 2018 |
Glutamine-induced signaling pathways via amino acid receptors in enteroendocrine L cell lines.
Topics: Animals; Cells, Cultured; Cyclic AMP; Enteroendocrine Cells; Glucagon-Like Peptide 1; Glutamine; L Cells; Mice; Receptors, Amino Acid; Receptors, G-Protein-Coupled; Secretory Pathway; Signal Transduction | 2020 |